Advertisements



Trillium Therapeutics doses first patient with TTI-622

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Cara Therapeutics doses first patient in Phase 2 trial of Korsuva for pruritus

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Aclaris Therapeutics doses first patient in Phase 2 clinical trial of ATI-501

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

Aclaris Therapeutics doses first patient in ATI-502 pilot study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: dealsSource: nytApr 23rd, 2018

Axsome Therapeutics announces completion of patient enrollment for ASCEND trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2018

Axovant Sciences doses first patient in AXO-Lenti-PD clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

As opioid crisis raged, Insys pushed higher doses of addictive drug and pushed salespeople to ‘own’ doctors

‘It is much easier to take an existing patient and double their units,’ one sales manager wrote, referring to patients as ‘low hanging fruit.’.....»»

Category: topSource: marketwatchOct 17th, 2018

Scynexis doses first patient in Phase 3 study of Ibrexafungerp

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

PTC Therapeutics announces initial data from patient registry

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2018

Trillium Therapeutics Updates On Lead Lymphoma Trials

Trillium Therapeutics Updates On Lead Lymphoma Trials.....»»

Category: topSource: seekingalphaOct 4th, 2018

Trillium Therapeutics provides updates on two clinical trials with TTI-621

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 28th, 2018

Apellis doses first patient in Phase 3 clinical program for APL-2 for GA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 12th, 2018

Spectrum expands poziotinib trial into first-line therapy, doses first patient

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 12th, 2018

Verastem doses first patient in Phase 1/2 trial of cancer combination candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2018

Celyad doses first colorectal cancer patient with CYAD-01

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2018

Juno Therapeutics and investors reach settlement related to fatal drug trial

The $24 million mediated settlement stems from a string of patient deaths that nearly derailed Seattle's star biotech startup two years ago......»»

Category: topSource: bizjournalsSep 2nd, 2018

Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study

Inovio Pharmaceuticals (INO) doses the first patient in a phase I/II study, which will evaluate its HIV vaccine Pennvax-GP's abil.....»»

Category: dealsSource: nytAug 16th, 2018

Inovio doses first patient in Phase 1/2 study of INO-5401

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Spark Therapeutics stock plummets 28% premarket on hemophilia trial"s patient safety concerns

Spark Ther.....»»

Category: topSource: marketwatchAug 7th, 2018

Spark Therapeutics stock plummets 25% premarket on hemophilia trial"s patient safety concerns

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 7th, 2018

Cara doses first patient in second pivotal Phase 3 efficacy trial of KORSUVA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018